首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   169篇
  免费   0篇
化学   166篇
物理学   3篇
  2022年   1篇
  2021年   2篇
  2020年   3篇
  2019年   6篇
  2018年   1篇
  2017年   2篇
  2016年   2篇
  2014年   3篇
  2013年   12篇
  2012年   7篇
  2011年   11篇
  2010年   8篇
  2009年   6篇
  2008年   6篇
  2007年   3篇
  2006年   5篇
  2005年   13篇
  2004年   15篇
  2003年   14篇
  2002年   12篇
  1994年   2篇
  1993年   3篇
  1992年   2篇
  1988年   1篇
  1984年   3篇
  1981年   1篇
  1980年   6篇
  1979年   4篇
  1978年   3篇
  1977年   1篇
  1976年   1篇
  1975年   4篇
  1974年   2篇
  1973年   2篇
  1972年   1篇
  1926年   1篇
排序方式: 共有169条查询结果,搜索用时 15 毫秒
1.
A synthetic approach towards the novel anti-inflammatory diterpenoid rameswaralide from the cis-Corey lactone involving a tandem RCM and Diels-Alder reaction has been conceived and endeavors so far have led to the acquisition of the BCD ring fragment of the natural product.  相似文献   
2.
A new family of annulated inositols (inosito-inositols) has been conceptualized. Naphthalene has been elaborated into novel cyclohexa-annulated neo- and chiro-inositols, with two additional hydroxyl functionalities, through a series of stereoselective oxyfunctionalization protocols. The trans-ring fusion present in these new annulated inositols ensures conformational locking.  相似文献   
3.
A new enzyme mediated protocol to access versatile chiral building blocks for the synthesis of epoxyquinone natural products is delineated. Total syntheses of (−)-phyllostine, (+)-epoxydon, (+)-epiepoxydon and (−)-panepophenanthrin have been accomplished to demonstrate the efficacy of this approach.  相似文献   
4.
5.
6.
The first enantiospecific approach to garsubellin A and related phloroglucin natural product nemorosone, of contemporary interest from (−)-α-pinene, has been delineated. Through a series of stereospecific operations, the requisite stereochemistry of the prenyl groups has been secured. Kende cyclization has been employed as the key step to construct the functionalized bicyclo[3.3.1]nonane core.  相似文献   
7.
Short, simple and enantioselective syntheses of the natural product (+)-streptol, the non-peptide apoptosis inhibitor ent-RKTS-33 and the putative structure of ‘parasitenone’ have been accomplished from the readily available chiral building block. ‘Parasitenone’ has been shown to be identical with the known natural product epoxydon.  相似文献   
8.
An oxy-Cope protocol has been grafted on to a previously crafted hydroazulenic system to provide a facile entry into the 5,11-fused bicyclic skeleton present in the novel neodolabellane diterpenoids. Formation of a novel tricyclic diterpenoid framework, generated through a transannular cyclization in the 11-membered ring present in the neodolabellane skeleton and embodying a bridged cycloheptatriene moiety, has also been encountered.  相似文献   
9.
An enantioselective total synthesis of the novel natural product (+)-panepophenanthrin has been accomplished in which a biomimetic Diels-Alder dimerisation is a key step. The monomeric precursor 2 was assembled from the readily available Diels-Alder adduct of cyclopentadiene and p-benzoquinone through a short, simple sequence employing chemo- and stereoselective operations.  相似文献   
10.
In chemistry and other sciences, hype has become commonplace, compounded by the hypocrisy of those who tolerate or encourage it while disapproving of the consequences. This reduces the credibility and trust upon which all science depends for support. Hype and hypocrisy are but first steps down a slippery slope towards falsification of results and dissemination of fake science. Systemic drivers in the contemporary structure of the science establishment encourage exaggeration and may lure the individual into further steps along the hype-hypocrisy-falsification-fakery continuum. Collective, concerted intervention is required to effectively discourage entry to this dangerous pathway and to restore and protect the probity and reputation of the science system. Chemists must play and active role in this effort.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号